See more : circlace Inc (5029.T) Income Statement Analysis – Financial Results
Complete financial analysis of Community Health Systems, Inc. (CYH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Community Health Systems, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- ResMed Inc. (RMD) Income Statement Analysis – Financial Results
- Bank Leumi Le-Israel B.M. (LUMI.TA) Income Statement Analysis – Financial Results
- Hansa Investment Company Limited (HANA.L) Income Statement Analysis – Financial Results
- Adobe Inc. (0R2Y.L) Income Statement Analysis – Financial Results
- Eli Lilly and Company (LLY.SW) Income Statement Analysis – Financial Results
Community Health Systems, Inc. (CYH)
About Community Health Systems, Inc.
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49B | 12.21B | 12.37B | 11.79B | 13.21B | 14.16B | 15.35B | 18.44B | 19.44B | 18.64B | 13.00B | 13.03B | 11.91B | 11.40B | 12.11B | 10.84B | 7.13B | 4.37B | 3.74B | 3.33B | 2.83B | 2.20B | 1.69B | 1.34B | 1.08B |
| Cost of Revenue | 7.41B | 7.31B | 7.28B | 7.37B | 8.10B | 8.74B | 10.05B | 11.64B | 12.04B | 11.48B | 8.21B | 8.08B | 1.83B | 1.77B | 6.53B | 5.85B | 3.84B | 2.25B | 1.93B | 1.74B | 912.80M | 1.38B | 323.81M | 259.47M | 209.08M |
| Gross Profit | 5.08B | 4.91B | 5.08B | 4.42B | 5.11B | 5.42B | 5.31B | 6.80B | 7.40B | 7.16B | 4.79B | 4.95B | 10.07B | 9.63B | 5.58B | 4.99B | 3.29B | 2.11B | 1.80B | 1.59B | 1.92B | 817.99M | 1.37B | 1.08B | 870.87M |
| Gross Profit Ratio | 40.69% | 40.18% | 41.11% | 37.45% | 38.70% | 38.26% | 34.55% | 36.90% | 38.06% | 38.41% | 36.82% | 38.00% | 84.60% | 84.46% | 46.08% | 46.08% | 46.13% | 48.42% | 48.25% | 47.80% | 67.80% | 37.17% | 80.88% | 80.60% | 80.64% |
| Research & Development | 80.00M | 85.00M | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 2.49B | 1.54B | 1.23B | 1.10B | 1.49B | 1.84B | 1.06B | 825.29M | 683.96M |
| Other Expenses | 3.73B | 3.70B | 3.35B | 2.91B | 3.91B | 4.19B | 4.70B | 5.28B | 5.53B | 5.24B | 3.50B | 3.47B | 4.89B | 4.60B | 4.26B | 1.71B | 316.22M | 191.57M | 167.67M | 158.26M | 145.75M | 120.45M | 119.67M | 97.62M | 81.65M |
| Operating Expenses | 4.13B | 4.01B | 3.66B | 3.24B | 4.23B | 4.53B | 5.09B | 5.73B | 5.99B | 5.68B | 3.78B | 3.74B | 9.00B | 8.51B | 4.51B | 9.86B | 2.80B | 1.73B | 1.40B | 1.25B | 1.63B | 1.96B | 1.18B | 922.92M | 765.61M |
| Cost & Expenses | 11.53B | 11.32B | 10.94B | 10.62B | 12.33B | 13.27B | 15.14B | 17.36B | 18.03B | 17.16B | 12.00B | 11.82B | 10.84B | 10.28B | 11.04B | 9.86B | 6.64B | 3.99B | 3.33B | 2.99B | 2.54B | 1.96B | 1.50B | 1.18B | 974.70M |
| Interest Income | 2.00M | 2.00M | 3.00M | 3.00M | 3.00M | 7.00M | 11.00M | 0.00 | 0.00 | 0.00 | 2.98M | 0.00 | 4.65M | 1.76M | 3.56M | 7.06M | 8.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 832.00M | 858.00M | 885.00M | 1.03B | 1.04B | 976.00M | 931.00M | 962.00M | 973.00M | 972.00M | 615.15M | 622.93M | 649.06M | 653.68M | 648.96M | 658.98M | 364.53M | 102.30M | 94.61M | 77.86M | 71.09M | 62.86M | 94.55M | 0.00 | 0.00 |
| Depreciation & Amortization | 505.00M | 534.00M | 540.00M | 558.00M | 608.00M | 700.00M | 861.00M | 1.10B | 1.17B | 1.19B | 782.68M | 725.56M | 657.67M | 609.84M | 566.54M | 506.69M | 332.58M | 188.77M | 166.16M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| EBITDA | 1.54B | 1.74B | 1.93B | 2.02B | 1.23B | 970.00M | -1.00B | 307.00M | 2.57B | 2.42B | 1.63B | 1.86B | 1.78B | 1.77B | 1.66B | 1.53B | 824.19M | 569.23M | 571.70M | 500.85M | 434.54M | 359.73M | 308.71M | 252.74M | 186.91M |
| EBITDA Ratio | 12.36% | 11.79% | 16.07% | 14.78% | 11.39% | 11.37% | 7.11% | 12.03% | 13.61% | 14.57% | 14.05% | 15.18% | 14.54% | 15.13% | 13.72% | 13.75% | 11.86% | 13.04% | 15.29% | 14.94% | 15.33% | 16.35% | 18.23% | 18.90% | 17.31% |
| Operating Income | 957.00M | 821.00M | 1.40B | 1.13B | 896.00M | 208.00M | -1.88B | -860.00M | 1.34B | 1.38B | 899.76M | 1.21B | 1.13B | 1.11B | 1.07B | 983.57M | 485.69M | 380.46M | 405.53M | 338.87M | 290.77M | 241.51M | 189.04M | 155.11M | 105.26M |
| Operating Income Ratio | 7.66% | 6.72% | 11.34% | 9.55% | 6.78% | 1.47% | -12.23% | -4.66% | 6.88% | 7.40% | 6.92% | 9.29% | 9.53% | 9.78% | 8.83% | 9.07% | 6.81% | 8.72% | 10.85% | 10.17% | 10.26% | 10.98% | 11.16% | 11.60% | 9.75% |
| Total Other Income/Expenses | -750.00M | -472.00M | -903.00M | -704.00M | -1.08B | -923.00M | -955.00M | -855.00M | -926.00M | -997.00M | -611.14M | -706.35M | -660.94M | -606.49M | -622.54M | -607.34M | -378.39M | -104.10M | -94.61M | -72.44M | -71.09M | -62.86M | -94.55M | -127.37M | -116.49M |
| Income Before Tax | 207.00M | 349.00M | 499.00M | 422.00M | -430.00M | -715.00M | -2.83B | -1.72B | 411.00M | 342.00M | 305.86M | 503.77M | 473.55M | 508.43M | 446.13M | 336.14M | 102.90M | 278.16M | 310.92M | 260.22M | 219.68M | 178.65M | 94.50M | 27.74M | -11.24M |
| Income Before Tax Ratio | 1.66% | 2.86% | 4.03% | 3.58% | -3.26% | -5.05% | -18.45% | -9.30% | 2.11% | 1.83% | 2.35% | 3.87% | 3.98% | 4.46% | 3.68% | 3.10% | 1.44% | 6.37% | 8.32% | 7.81% | 7.75% | 8.12% | 5.58% | 2.07% | -1.04% |
| Income Tax Expense | 191.00M | 170.00M | 131.00M | -185.00M | 160.00M | -11.00M | -449.00M | -104.00M | 116.00M | 82.00M | 88.59M | 157.50M | 137.65M | 159.99M | 141.33M | 129.48M | 43.00M | 106.68M | 120.78M | 102.00M | 88.21M | 73.39M | 45.94M | 18.17M | 5.55M |
| Net Income | -133.00M | 179.00M | 368.00M | 511.00M | -590.00M | -788.00M | -2.46B | -1.72B | 158.00M | 92.00M | 141.20M | 265.64M | 201.95M | 279.98M | 243.15M | 218.30M | 30.29M | 168.26M | 167.54M | 151.43M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Net Income Ratio | -1.06% | 1.47% | 2.98% | 4.33% | -4.47% | -5.57% | -16.02% | -9.33% | 0.81% | 0.49% | 1.09% | 2.04% | 1.70% | 2.46% | 2.01% | 2.01% | 0.42% | 3.85% | 4.48% | 4.54% | 4.64% | 4.54% | 2.64% | 0.72% | -1.55% |
| EPS | -1.02 | 1.39 | 2.90 | 4.42 | -5.19 | -6.99 | -22.00 | -15.55 | 1.38 | 0.82 | 1.51 | 2.98 | 2.24 | 3.05 | 2.68 | 2.34 | 0.32 | 1.77 | 1.89 | 1.58 | 1.34 | 1.02 | 0.51 | 0.14 | -0.31 |
| EPS Diluted | -1.02 | 1.38 | 2.82 | 4.38 | -5.19 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.51 | 2.96 | 2.23 | 3.01 | 2.66 | 2.32 | 0.32 | 1.75 | 1.79 | 1.51 | 1.30 | 1.00 | 0.50 | 0.14 | -0.31 |
| Weighted Avg Shares Out | 130.39M | 128.81M | 126.75M | 115.49M | 113.74M | 112.73M | 111.77M | 110.71M | 114.00M | 112.00M | 92.63M | 89.24M | 89.97M | 91.72M | 90.62M | 93.37M | 93.52M | 94.98M | 88.60M | 95.64M | 98.39M | 98.42M | 88.38M | 67.61M | 54.55M |
| Weighted Avg Shares Out (Dil) | 130.45M | 130.06M | 130.60M | 116.54M | 113.74M | 112.73M | 111.77M | 110.73M | 115.00M | 113.00M | 93.82M | 89.81M | 90.67M | 92.95M | 91.52M | 94.29M | 94.64M | 96.23M | 98.58M | 100.29M | 101.13M | 108.38M | 90.25M | 69.19M | 54.55M |
Community Health Systems, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CYH
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
Investors Of Community Health Systems Inc Eligible To Join Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 8, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or "the...
CYH ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Community Health Systems, Inc. investment
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
Investors Of Community Health Systems Inc Can Join Fraud Investigation With The Schall Law Firm
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or "the Company") (NYSE: CYH ) for violations of the securities laws....
Community Health Systems, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Community Health (CYH)
NEW YORK, NY / ACCESSWIRE / August 6, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
Community Health Systems Inc Investors Can Participate In Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or "the...
Levi & Korsinsky Reminds Shareholders of an Investigation into Community Health Systems, Inc. (CYH) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
Shareholder Rights Advocates at Levi & Korsinsky Investigate Community Health Systems, Inc. (CYH) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
Lost Money on Community Health Systems, Inc.(CYH)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 3, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Community Health Systems, Inc. ("Community Health") (NYSE:CYH) concerning possible violations of federal securities laws. Community Health issued a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Source: https://incomestatements.info
Category: Stock Reports